These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 30236958

  • 21. Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
    Thelen H, Dilworth TJ, Mercier RC.
    Chemotherapy; 2022; 67(4):261-268. PubMed ID: 36417841
    [Abstract] [Full Text] [Related]

  • 22. Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.
    Thulin E, Thulin M, Andersson DI.
    EBioMedicine; 2017 Sep; 23():111-118. PubMed ID: 28855073
    [Abstract] [Full Text] [Related]

  • 23. In-vitro activity of the combinations of ampicillin with mecillinam or with beta-lactamase inhibitors against strains resistant to ampicillin.
    Verbist L.
    J Antimicrob Chemother; 1985 Dec; 16(6):719-25. PubMed ID: 3879248
    [Abstract] [Full Text] [Related]

  • 24. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C, Gracia M, Giménez MJ, Aguilar L, Maín CM, Carpintero Y, Huelves L, Carcas A, del Prado G, Soriano F.
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [Abstract] [Full Text] [Related]

  • 25. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
    Zykov IN, Sundsfjord A, Småbrekke L, Samuelsen Ø.
    Infect Dis (Lond); 2016 Feb; 48(2):99-107. PubMed ID: 26414659
    [Abstract] [Full Text] [Related]

  • 26. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W, Jarlier V.
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [Abstract] [Full Text] [Related]

  • 27. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R, Duval J.
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
    Bémer-Melchior P, Gilly L, Jugroot-Klotz K, Brun T, Névot P, Paul G.
    Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of mecillinam against clinical multidrug-resistant Escherichia coli in a murine urinary tract infection model.
    Zykov IN, Frimodt-Møller N, Småbrekke L, Sundsfjord A, Samuelsen Ø.
    Int J Antimicrob Agents; 2020 Feb; 55(2):105851. PubMed ID: 31770624
    [Abstract] [Full Text] [Related]

  • 32. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
    Alou L, Aguilar L, Sevillano D, Giménez MJ, Cafini F, Valero E, Relaño MT, Prieto J.
    J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
    [Abstract] [Full Text] [Related]

  • 33. Emerging clinical role of pivmecillinam in the treatment of urinary tract infections caused by Extended Spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS.
    Int J Clin Pract; 2019 Sep; 73(9):1-5. PubMed ID: 31243859
    [Abstract] [Full Text] [Related]

  • 34. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY, Chang SC, Luh KT, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [Abstract] [Full Text] [Related]

  • 35. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.
    Sirot D, Chanal C, Henquell C, Labia R, Sirot J, Cluzel R.
    J Antimicrob Chemother; 1994 Jun; 33(6):1117-26. PubMed ID: 7928805
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R.
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [Abstract] [Full Text] [Related]

  • 37. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
    Neu HC.
    Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
    [Abstract] [Full Text] [Related]

  • 38. Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes.
    Fuglesang JE, Bergan T.
    Infection; 1983 Sep; 11(6):329-35. PubMed ID: 6365790
    [Abstract] [Full Text] [Related]

  • 39. Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum β-lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model.
    Zhanel GG, Denisuik A, Vashisht S, Yachison C, Adam HJ, Hoban DJ.
    J Antimicrob Chemother; 2014 Sep; 69(9):2448-52. PubMed ID: 24827891
    [Abstract] [Full Text] [Related]

  • 40. A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines.
    Vanstokstraeten R, Belasri N, Demuyser T, Crombé F, Barbé K, Piérard D.
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2371-2377. PubMed ID: 34175999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.